“Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in the Phase 3 POETYK PSO-1 and PSO-2 Trials ”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s364, https://doi.org/10.25251/skin.8.supp.364.